menu search

AERI / Why Aerie Pharmaceuticals Was Soaring So High This Week

Why Aerie Pharmaceuticals Was Soaring So High This Week
You'd vault skyward, too, if a big-pocketed company were willing to spend a lot of coin on acquiring you. Read More
Posted: Aug 26 2022, 09:03
Author Name: The Motley Fool
Views: 102117

AERI News  

Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates

By Zacks Investment Research
November 3, 2022

Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates

Aerie (AERI) delivered earnings and revenue surprises of 35.71% and 2.91%, respectively, for the quarter ended September 2022. Do the numbers hold clu more_horizontal

Why Aerie Pharmaceuticals Was Soaring So High This Week

By The Motley Fool
August 26, 2022

Why Aerie Pharmaceuticals Was Soaring So High This Week

You'd vault skyward, too, if a big-pocketed company were willing to spend a lot of coin on acquiring you. more_horizontal

Aerie Pharmaceuticals, Inc.'s (AERI) CEO Raj Kannan on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
August 7, 2022

Aerie Pharmaceuticals, Inc.'s (AERI) CEO Raj Kannan on Q2 2022 Results - Earnings Call Transcript

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Hans Vitzthum – Investor more_horizontal

Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease

By Zacks Investment Research
May 25, 2022

Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease

Aerie Pharmaceutials (AERI) doses the first patient in a phase III study on its investigational TRMP8 agonist drug for the treatment of dry eye diseas more_horizontal

Aerie Pharmaceuticals' (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 7, 2022

Aerie Pharmaceuticals' (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call Transcript

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Hans Vitzthum – LifeSci Part more_horizontal

Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y

By Zacks Investment Research
May 6, 2022

Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y

Aerie (AERI) misses on both earnings and revenues for the first quarter of 2022. more_horizontal

Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates

By Zacks Investment Research
May 5, 2022

Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates

Aerie (AERI) delivered earnings and revenue surprises of -1.54% and 1.17%, respectively, for the quarter ended March 2022. Do the numbers hold clues t more_horizontal

Aerie Pharmaceuticals (AERI) Stock: Why It Substantially Increased

By Pulse2
February 27, 2022

Aerie Pharmaceuticals (AERI) Stock: Why It Substantially Increased

The Aerie Pharmaceuticals Inc (NASDAQ: AERI) stock increased by 29.49% in the most recent trading session. This is why. more_horizontal


Search within

Pages Search Results: